Drugs / Inactivated H1N1 Vaccine
Inactivated H1N1 Vaccine
Trials 8 · a red edge is where a trial was stopped
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT01097941 Comparator | Mar → Sep 2010 | swine influenza | University of Rochester | Withdrawn | No outcome recorded |
Evidence & citations 8 cited values
Every value below carries the sentence it was read from. 12 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Inactivated H1N1 Vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00943488 ↗ |
| Known as | 2009 H1N1 vaccine | “monovalent 2009 H1N1 influenza vaccine (2009 H1N1 vaccine)” PMID 22802432 ↗ Jul 2012 |
| Known as | CSL vaccine | “who received CSL vaccine.” PMID 22537984 ↗ Apr 2012 |
| Known as | Fluvirin | “Two 30-μg doses of 2009 Novartis pH1N1 monovalent vaccine (Fluvirin) were administered 21-28 days apart” PMID 22615311 ↗ May 2012 |
| Known as | Influenza A (H1N1) 2009 Monovalent Vaccine | “H1N1 vaccine \[Influenza A (H1N1) 2009 Monovalent Vaccine\] is a licensed, inactivated influenza virus vaccine.” NCT00992719 ↗ |
| Known as | monovalent 2009 H1N1 influenza vaccine | “monovalent 2009 H1N1 influenza vaccine (2009 H1N1 vaccine)” PMID 22802432 ↗ Jul 2012 |
| Modality | Vaccine | “Inactivated influenza H1N1 vaccine, 15 micrograms per dose.” NCT00943202 ↗ |
| Route | Intramuscular | “Vaccines will be administered as a single 0.5 mL intramuscular injection” NCT00943202 ↗ |